[Diagnosis, treatment, and prophylaxis for cytomegalovirus disease following allogeneic stem cell transplantation].
Hisashi
H
Gondo
D000998:Antiviral Agents / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D004279:DNA, Viral / Q000032:analysis; D015774:Ganciclovir / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D015166:Monitoring, Immunologic; D021141:Nucleic Acid Amplification Techniques; D016133:Polymerase Chain Reaction; D013601:T-Lymphocytes / Q000276:immunology
D000998:Antiviral Agents; D004279:DNA, Viral; D007166:Immunosuppressive Agents; D015774:Ganciclovir